LSE:ERGO (Ergomed Plc)

About ERGO

Ergomed Plc is a clinical stage development company, which provides specialist services to the pharmaceutical and biotechnology industries spanning all phases of clinical development, post-approval pharmacovigilance, and medical information. It operates through the following business segments: Clinical Research Services (CRO) and Pharmacovigilance (PV). The CRO segment is engaged in process of developing medical therapies, drugs, and knowledge for safe use in healthcare. The PV segment is involved in the activities relating to the detection, understanding, and prevention of adverse effects or other drug-related problems throughout its lifecycle. The company was founded by Miroslav Reljanovic in 1997 and is headquartered in Guildford, the United Kingdom.

Ergomed Plc (LSE: ERGO) Latest News

Two gay men are walking through a Victorian shopping arcade
Investing Articles

8 shares that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying shares in these equities in recent weeks.

Read more »

Investing Articles

I just bought these beaten-up growth stocks for my ISA

Edward Sheldon just snapped up two new stocks for his ISA. Both are currently well off their 52-week highs, meaning…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

3 dirt cheap growth shares to buy right now?

Forget investing in defensive stocks during market weakness, I reckon this is a great time to buy some cheap growth…

Read more »

British union jack flag and Parliament house at city of Westminster in the background
Investing Articles

3 AIM shares that are worth a look right now

AIM shares can provide strong returns over the long term. Here, Edward Sheldon highlights three he likes the look of…

Read more »

Girl buying groceries in the supermarket with her father.
Investing Articles

Just released: the 3 best small-cap stocks to buy now [PREMIUM PICKS]

Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

Read more »

Genetic Techs with the text “Investing in Genetics Top UK Genetics Stocks in 2022” and The Motley Fool jester cap logo
Page

Investing in Genetics: Top UK Genetics Stocks of 2025

Explore the world of UK genetics stocks and discover the leading businesses offering explosive growth potential. Here’s what you need…

Read more »

Investing Articles

How I’d look to turn a £1,000 investment in UK growth shares into £5,000

There are UK growth shares in both the FTSE and AIM markets, contrary to the view of some investors that…

Read more »

Investing Articles

2 UK biotech stocks to watch in 2021

Combined, these two biotech stocks are up 100% over the last 12 months! Zaven Boyrazian takes a closer look at…

Read more »

Investing Articles

Alongside AstraZeneca, I’d buy this small-cap share in the pharmaceutical sector

AstraZeneca’s R&D pipeline is producing new treatments, while this cash-rich small-cap is engaged in studies aimed at treating the symptoms…

Read more »

Investing Articles

AstraZeneca and this small growth pharma stock could make you brilliantly rich

Harvey Jones finds a racy little pharma stock to sit beside dividend and growth monster AstraZeneca plc (LON: AZN) in…

Read more »

Buy Signal ROI
Investing Articles

GlaxoSmithKline plc isn’t the only pharma stock worth investing in for retirement

This company could generate high returns alongside GlaxoSmithKline plc (LON:GSK) (GSK.L).

Read more »

Investing Articles

A small-cap growth stock I’d buy alongside Premier Oil plc in 2018

Premier Oil plc (LON: PMO) could finally be on the up, and here's another potential growth winner I'd buy too.

Read more »